The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major diabetic nephropathy markets reached a value of US$ 9,717.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14,572.9 Million by 2034, exhibiting a growth rate (C...
May 2024
134 pages
Diabetic Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major diabetic peripheral neuropathy markets reached a value of US$ 2,903.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,365.9 Million by 2034, exhibiting a growt...
May 2024
134 pages
Doose Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major doose syndrome markets reached a value of US$ 687.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,160.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...
May 2024
136 pages
Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...
May 2024
137 pages
Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...
May 2024
131 pages
